Sanchez Benjamin, Rutkove Seward B
Department of Neurology, Division of Neuromuscular Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, TCC-810, Boston, MA, 02215, USA.
Curr Neurol Neurosci Rep. 2017 Sep 20;17(11):86. doi: 10.1007/s11910-017-0793-3.
In this article, we provide an overview of electrical impedance myography (EIM), including its technical and theoretical basis, a summary of its varied applications, and ongoing developments.
EIM has been used as a disease severity biomarker in a variety of disorders affecting the muscle, ranging from amyotrophic lateral sclerosis (ALS) to muscular dystrophies to disuse atrophy due to the weightlessness of space. In ALS, studies have demonstrated that major reductions in sample size in clinical trials can be achieved. Similarly, in the Duchenne muscular dystrophy, the technique tracks disease progression and is sensitive to the beneficial effect of steroids. More basic work has demonstrated that EIM can provide a non-invasive means of tracking muscle fiber size. Ongoing innovations include the development of techniques for assessing muscle contraction. EIM is gradually being adopted as a useful, practical, and convenient tool for the assessment of neuromuscular conditions.
在本文中,我们对电阻抗肌动描记术(EIM)进行概述,包括其技术和理论基础、各种应用的总结以及当前的进展情况。
EIM已被用作多种影响肌肉疾病的疾病严重程度生物标志物,范围从肌萎缩侧索硬化症(ALS)到肌肉营养不良症,再到因太空失重导致的废用性萎缩。在ALS中,研究表明可以在临床试验中大幅减少样本量。同样,在杜氏肌营养不良症中,该技术可追踪疾病进展,并且对类固醇的有益效果敏感。更多基础研究表明,EIM能够提供一种追踪肌纤维大小的非侵入性方法。当前的创新包括用于评估肌肉收缩技术的开发。EIM正逐渐成为评估神经肌肉状况的一种有用、实用且便捷的工具。